Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal progesterone for latent phase prolongation in PPROM
IRCT20200610047716N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone in Preterm prelabor rupture of membranes (PPROM), sponsored by Golestan University of Medical Sciences. Started Dec 2019; status: completed.
02
Drugs
progesterone
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT20200610047716N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200610047716N1.